FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis

Development

Volumn 137, Issue 12, 2010, Pages 2045-2054

  Bernardo, Gina M ^a   Lozada, Kristen L ^a   Miedler, John D ^b   Harburg, Gwyndolen ^c   Hewitt, Sylvia C ^d   Mosley, Jonathan D ^e   Godwin, Andrew K ^f   Korach, Kenneth S ^d   Visvader, Jane E ^c   Kaestner, Klaus H ^g   Abdul Karim, Fadi W ^a,b   Montano, Monica M ^a   Keri, Ruth A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; ER ; FOXA1; GATA3; Mammary gland; Mouse

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BUDDING; CANCER CELL CULTURE; CANCER INVASION; CELL EXPANSION; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; FEMALE; HORMONAL CARCINOGENESIS; HORMONE RESPONSE; MALE; MAMMARY GLAND; MILK PRODUCTION; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

BREAST; BREAST NEOPLASMS; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MORPHOGENESIS;

EID: 77953080874     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.043299     Document Type: Article

References (49)

1. Abramoff, M. D., Magelhaes, P. J. and Ram, S. J. (2004). Image Processing with Image J. Biophotonics International 11, 36-42.
2. Asselin-Labat, M. L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J. et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201-209.
3. Badve, S., Turbin, D., Thorat, M. A., Morimiya, A., Nielsen, T. O., Perou, C. M., Dunn, S., Huntsman, D. G. and Nakshatri, H. (2007). FOXA1 expression in breast cancer-correlation with luminal subtype A and survival. Clin. Cancer Res. 13, 4415-4421.
4. Behr, R., Brestelli, J., Fulmer, J. T., Miyawaki, N., Kleyman, T. R. and Kaestner, K. H. (2004). Mild nephrogenic diabetes insipidus caused by Foxa1 deficiency. J. Biol. Chem 279, 41936-41941.
5. Besnard, V., Wert, S. E., Kaestner, K. H. and Whitsett, J. A. (2005). Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L750-L759.
6. Brisken, C., Park, S., Vass, T., Lydon, J. P., O'Malley, B. W. and Weinberg, R. A. (1998). A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. USA 95, 5076-5081.
7. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove, E. A. and Sutherland, R. L. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-2133.
8. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R. et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
9. Chakravarty, G., Hadsell, D., Buitrago, W., Settleman, J. and Rosen, J. M. (2003). p190-B RhoGAP regulates mammary ductal morphogenesis. Mol. Endocrinol. 17, 1054-1065.
10. Ciarloni, L., Mallepell, S. and Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc. Natl. Acad. Sci. USA 104, 5455-5460.
11. Clarke, R. B., Howell, A. and Anderson, E. (1997). Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res. Treat. 45, 121-133.
12. Cunha, G. R., Hom, Y. K., Young, P. and Brody, J. (2000). Transplantation and tissue recombination techniques to study mammary gland biology. In Methods in Mammary Gland Biology and Breast Cancer Research, vol. 1 (ed. M. M. Ip and B. B. Asch), pp. 289-306. New York: Kluwer Academic/Plenum Publishers.
13. Daniel, C. W., Silberstein, G. B., Van Horn, K., Strickland, P. and Robinson, S. (1989). TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev. Biol. 135, 20-30.
14. Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P. and Mark, M. (2000). Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127, 4277-4291.
15. EBCTCG (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687-1717.
16. Eeckhoute, J., Carroll, J. S., Geistlinger, T. R., Torres-Arzayus, M. I. and Brown, M. (2006). A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev. 20, 2513-2526.
17. Eeckhoute, J., Keeton, E. K., Lupien, M., Krum, S. A., Carroll, J. S. and Brown, M. (2007). Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 67, 6477-6483.
18. Feng, Y., Manka, D., Wagner, K. U. and Khan, S. A. (2007). Estrogen receptoralpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl. Acad. Sci. USA 104, 14718-14723.
19. Gao, N., Ishii, K., Mirosevich, J., Kuwajima, S., Oppenheimer, S. R., Roberts, R. L., Jiang, M., Yu, X., Shappell, S. B., Caprioli, R. M. et al. (2005). Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 132, 3431-3443.
20. Habashy, H. O., Powe, D. G., Rakha, E. A., Ball, G., Paish, C., Gee, J., Nicholson, R. I. and Ellis, I. O. (2008). Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. Eur. J. Cancer 44, 1541-1551.
21. Haslam, S. Z. and Nummy, K. A. (1992). The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. J. Steroid Biochem. Mol. Biol. 42, 589-595.
22. Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., 3rd and Hynes, N. E. (2003). The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl. Acad. Sci. USA 100, 8933-8938.
23. Jackson-Fisher, A. J., Bellinger, G., Breindel, J. L., Tavassoli, F. A., Booth, C. J., Duong, J. K. and Stern, D. F. (2008). ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res. 10, R96.
24. Kaestner, K. H., Katz, J., Liu, Y., Drucker, D. J. and Schutz, G. (1999). Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 13, 495-504. (Pubitemid 29108764)
25. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. and Werb, Z. (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055.
26. Kouros-Mehr, H., Bechis, S. K., Slorach, E. M., Littlepage, L. E., Egeblad, M., Ewald, A. J., Pai, S. Y., Ho, I. C. and Werb, Z. (2008). GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13, 141-152.
27. Laganiere, J., Deblois, G., Lefebvre, C., Bataille, A. R., Robert, F. and Giguere, V. (2005). From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102, 11651-11656.
28. Li, M., Liu, X., Robinson, G., Bar-Peled, U., Wagner, K. U., Young, W. S., Hennighausen, L. and Furth, P. A. (1997). Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA 94, 3425-3430.
29. Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S. and Brown, M. (2008). FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-970.
30. Mallepell, S., Krust, A., Chambon, P. and Brisken, C. (2006). Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. USA 103, 2196-2201.
31. McBryan, J., Howlin, J., Napoletano, S. and Martin, F. (2008). Amphiregulin: role in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 13, 159-169.
32. Mehra, R., Varambally, S., Ding, L., Shen, R., Sabel, M. S., Ghosh, D., Chinnaiyan, A. M. and Kleer, C. G. (2005). Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 65, 11259-11264.
33. Mueller, S. O., Clark, J. A., Myers, P. H. and Korach, K. S. (2002). Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 143, 2357-2365.
34. Parsa, S., Ramasamy, S. K., De Langhe, S., Gupte, V. V., Haigh, J. J., Medina, D. and Bellusci, S. (2008). Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev. Biol. 317, 121-131.
35. Rasmussen, S. B., Young, L. J. T. and Smith, G. H. (2000). Preparing Mammary Gland Whole Mounts from Mice. In Methods in Mammary Gland Biology and Breast Cancer Research, vol. 1 (ed. M. M. Ip and B. B. Asch), pp. 75-85. New York: Kluwer Academic/Plenum Publishers.
36. Reid, G., Denger, S., Kos, M. and Gannon, F. (2002). Human estrogen receptoralpha: regulation by synthesis, modification and degradation. Cell Mol. Life Sci. 59, 821-831.
37. Richert, M. M., Schwertfeger, K. L., Ryder, J. W. and Anderson, S. M. (2000). An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 5, 227-241.
38. Robinson, G. W., Accili, D. and Hennighausen, L. (2000). Rescue of mammary epithelium of early lethal phenotypes by embryonic mammary gland transplantation as exemplified with insulin receptor null mice. In Methods in Mammary Gland Biology and Breast Cancer Research, vol. 1 (ed. M. M. Ip and B. B. Asch), pp. 307-316. New York: Kluwer Academic/Plenum Publishers.
39. Robinson, G. W., Wagner, K. U. and Hennighausen, L. (2001). Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20, 7115-7119.
40. Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. L., Wu, L., Lindeman, G. J. and Visvader, J. E. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88.
41. Shih, D. Q., Navas, M. A., Kuwajima, S., Duncan, S. A. and Stoffel, M. (1999). Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc. Natl. Acad. Sci. USA 96, 10152-10157.
42. Silberstein, G. B. and Daniel, C. W. (1987). Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 237, 291-293. (Pubitemid 17095150)
43. Smalley, M. and Ashworth, A. (2003). Stem cells and breast cancer: A field in transit. Nat. Rev. Cancer 3, 832-844. (Pubitemid 37376981)
44. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S. et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100, 8418-8423.
45. Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerod, A., Karesen, R., Oh, D. S., Dressler, L. G. et al. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23, 7669-7678.
46. Wakefield, L. M., Piek, E. and Bottinger, E. P. (2001). TGF-beta signaling in mammary gland development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 6, 67-82.
47. Williamson, E. A., Wolf, I., O'Kelly, J., Bose, S., Tanosaki, S. and Koeffler, H. P. (2006). BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene 25, 1391-1399.
48. Wiseman, B. S. and Werb, Z. (2002). Stromal effects on mammary gland development and breast cancer. Science 296, 1046-1049.
49. Wittmann, B. M., Fujinaga, K., Deng, H., Ogba, N. and Montano, M. M. (2005). The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene 24, 5576-5588.